Hillman Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Hillman Capital Management's WST Position: Q3 2026 in Review
Hillman Capital Management sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 7,106 shares — an estimated $2.55M sold.
Hillman Capital Management first reported a position in WST in Q3 2025 and held it in 4 quarters. The position peaked at $2.69M in Q3 2025. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Hillman Capital Management reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Hillman Capital Management sold 7,106 West Pharmaceutical shares in Q3 2026, an estimated $2.55M.
- Hillman Capital Management first reported a position in West Pharmaceutical in Q3 2025 and held it in 4 quarters.
- Hillman Capital Management's West Pharmaceutical position peaked at $2.69M in Q3 2025.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Hillman Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.